Sig Brokerage, LP Syndax Pharmaceuticals Inc Transaction History
Sig Brokerage, LP
- $1.87 Trillion
- Q4 2024
A detailed history of Sig Brokerage, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Sig Brokerage, LP holds 10,000 shares of SNDX stock, worth $159,900. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$159,900% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SNDX
# of Institutions
232Shares Held
96.9MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$136 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$126 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$95.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$85 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$78.1 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $904M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...